Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Transparency Panel Urges Agency To Make Records Of Denials Public
The Food and Drug Administration's Transparency Task Force has recommended that the agency should make more information about companies and the reasons behind decisions not to approve products available to the public.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
